US President Donald Trump recently made a significant announcement regarding pharmaceutical imports, revealing plans for a 100% tariff on branded or patented drugs starting October 1. This decision is likely to have substantial implications for Indian drugmakers, as the United States stands as their largest market, especially in the affordable generic medicines segment. The move could lead to increased prices for consumers and significant challenges for Indian pharmaceutical companies operating in the US market.
Trump announces 100% tariff on pharmaceutical products, Indian drugmakers expected to be impacted
-
Flamengo and PSG have faced each other three times; check out their record
-
Indonesia Open Footgolf Tournament: Comedian Oki Rengga Admits Addiction, Wants to Become a Professional Athlete
-
Shameful Incident in Punjab! Landlord Rolls Tenant’s Daughter
-
Virgil van Dijk Expresses Desire for Mohamed Salah to Stay at Liverpool
Deixe um comentário